Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L14 (MRPL14) is a nuclear-encoded protein that is an essential component of the 39S large subunit of the mitochondrial ribosome. It plays a structural role in the mitochondrial translation machinery, which synthesizes 13 essential polypeptides encoded by mitochondrial DNA, all of which are required for assembly and function of the oxidative phosphorylation (OXPHOS) complexes. MRPL14 interacts directly with other mitoribosome assembly factors, such as C7orf30, which is required for efficient incorporation of MRPL14 into the large subunit. Depletion of MRPL14 severely impairs mitochondrial ribosome biogenesis, resulting in diminished mitochondrial translation and compromised formation of respiratory chain complexes. There are no current drugs or therapeutics that target MRPL14, and it is not considered a classical therapeutic target such as a receptor, enzyme, or transporter[1][2][5].
Not applicable (no known drugs target this protein directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L14 (MRPL14).